In The News Posted October 31, 2019 Share Posted October 31, 2019 BOCA RATON, Fla., Oct. 30, 2019 /PRNewswire/ -- Mizner Bioscience, LLC., today announced that they received the first US FDA approval for a therapeutically equivalent generic version of Elanco's Clomicalm®, (Clomipramine Hydrochloride Tablets). Approved by the U.S. Food and Drug... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.